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Abstract
Age‐related	impairment	of	muscle	function	severely	affects	the	health	of	an	increas‐
ing	elderly	population.	While	causality	and	the	underlying	mechanisms	remain	poorly	
understood,	exercise	is	an	efficient	intervention	to	blunt	these	aging	effects.	We	thus	
investigated	the	role	of	the	peroxisome	proliferator‐activated	receptor	γ coactivator 
1α	 (PGC‐1α),	a	potent	regulator	of	mitochondrial	function	and	exercise	adaptation,	
in	 skeletal	muscle	 during	 aging.	We	demonstrate	 that	 PGC‐1α overexpression im‐
proves	mitochondrial	dynamics	and	calcium	buffering	in	an	estrogen‐related	recep‐
tor α‐dependent	manner.	Moreover,	we	show	that	sarcoplasmic	reticulum	stress	 is	
attenuated	 by	 PGC‐1α.	 As	 a	 result,	 PGC‐1α prevents tubular aggregate formation 
and	cell	death	pathway	activation	in	old	muscle.	Similarly,	the	pro‐apoptotic	effects	
of	ceramide	and	thapsigargin	were	blunted	by	PGC‐1α	 in	muscle	cells.	Accordingly,	
mice	with	muscle‐specific	gain‐of‐function	and	loss‐of‐function	of	PGC‐1α exhibit a 
delayed	and	premature	aging	phenotype,	 respectively.	Together,	our	data	 reveal	a	
key	protective	effect	of	PGC‐1α on muscle function and overall health span in aging.
K E Y W O R D S
aging,	calcium	homeostasis,	cell	death,	health	span,	mitochondria,	PGC‐1α, skeletal muscle, 
tubular aggregates
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1  | INTRODUC TION
Muscle	 strength	 and	mass	 progressively	 decline	with	 age,	 leading	
to physical disability, and ultimately higher morbidity and mortality. 
Although	 the	 cause	 of	muscle	 aging	 is	multifactorial,	 reduced	mi‐
tochondrial function is a commonly observed phenomenon associ‐
ated	with	muscle	deterioration	during	aging	 (Peterson,	Johannsen,	
&	 Ravussin,	 2012).	 For	 example,	 reduced	 mitochondrial	 biogene‐
sis, decreased mitochondrial mass and aberrant fission to fusion 
rates concomitant with a mitochondrial turnover drop have been 
reported	 in	 old	muscle.	 In	 addition,	 increased	mitochondrial	 DNA	
damage, depolarized and swollen mitochondria, diminished rates of 
oxidative	phosphorylation	(OXPHOS)	and	Krebs	cycle	activity	have	
been	 found	 in	 this	 context.	Collectively,	 the	ensuing	 reduced	ATP	
production, impaired calcium homeostasis, elevated apoptosis, and 
increased	 levels	of	 reactive	oxygen	species	 (ROS)	all	 contribute	 to	
age‐associated	muscle	dysfunction.
Importantly, mitochondria, together with the sarcoplasmic re‐
ticulum	(SR),	control	cellular	calcium	homeostasis	(Rizzuto,	Stefani,	
Raffaello,	&	Mammucari,	2012).	These	two	organelles	communicate	
via	 contact	 sites,	 termed	mitochondria‐associated	ER	membranes	
(MAMs),	focal	hotspots	for	the	exchange	of	calcium	as	well	as	the	
synthesis and transfer of phospholipids, initiation of mitochon‐
drial	 fission,	 mitophagy,	 and	 signal	 transduction	 events	 (Marchi,	
Patergnani,	&	Pinton,	2014).	Aging	 impairs	mitochondria‐SR	asso‐
ciation	and	mitochondrial	calcium	uptake	(Pietrangelo	et	al.,	2015),	
which can contribute to a dysregulation of cellular calcium homeo‐
stasis.	Furthermore,	all	three	structures,	mitochondria,	MAMs,	and	
the	SR,	have	been	linked	to	the	 initiation	of	cell	death	(Danese	et	
al.,	2017)	and	 increased	apoptosis	 levels	 in	old	muscle	 (Whitman,	
Wacker,	Richmond,	&	Godard,	2005).	For	example,	apoptosis	can	be	
mediated	 in	mitochondria	via	 caspase‐dependent	 and	caspase‐in‐
dependent	pathways,	both	of	which	are	rising	with	age	(Siu,	Pistilli,	
&	Alway,	2005).	In	addition,	mitochondrial	and	nuclear	DNA	dam‐
age	 due	 to	 increased	 ROS	 levels	 also	 contributes	 to	 age‐related	
muscle	 apoptosis	 (Harman,	 2006).	 Finally,	 endoplasmic	 reticulum	
(ER)	stress	is	also	a	strong	promoter	of	apoptotic	events	(Szegezdi,	
Logue,	Gorman,	&	Samali,	2006).
Important regulators of mitochondrial biogenesis and func‐
tion,	most	notably	the	peroxisome	proliferator‐activated	receptor	
γ coactivator 1α	 (PGC‐1α),	are	 reduced	 in	skeletal	muscle	 in	 the	
aging process and have been associated with the decrease in mi‐
tochondrial	function	(Ling	et	al.,	2004).	Importantly,	this	deterio‐
ration	can	partly	be	restored	by	exercise	(Kang,	Chung,	Diffee,	&	
Ji,	2013),	a	strong	promoter	of	PGC‐1α transcription and activity. 
In	 addition,	 transgenic	 overexpression	 of	 PGC‐1α extends lifes‐
pan in Drosophila melanogaster	 (Rera	et	al.,	2011).	Using	gain‐of‐
function	and	loss‐of‐function	mouse	models	for	muscle	PGC‐1α, 
we aimed at providing a unifying and comprehensive study deter‐
mining	the	role	of	PGC‐1α in muscle aging, in particular in regard 
to calcium homeostasis and cell death.
2  | RESULTS
2.1 | PGC‐1α modulates mitochondrial dynamics 
and SR association in the aging muscle
In light of the strong decline in mitochondrial function in aging, we first 
performed	a	broad	comparative	analysis	of	young	and	old	wild‐type	
(WT),	PGC‐1α	muscle‐specific	transgenic	(mTg‐PGC‐1α),	and	PGC‐1α 
muscle‐specific	knockout	(mKO‐PGC‐1α)	mice.	In	these	skeletal	mus‐
cle‐specific	gain‐of‐function	and	loss‐of‐function	models	for	PGC‐1α, 
many of these parameters have been extensively assessed and re‐
ported	 in	 young	 animals	 (Handschin,	 Chin,	 et	 al.,	 2007;	Handschin,	
Choi,	 et	 al.,	 2007;	Lin	et	 al.,	 2002),	but	data	 in	old	mice	are	 scarce.	
Mitochondrial	 fission	and	 fusion	events	are	essential	 for	proper	mi‐
tochondrial physiology, but these programs controlling mitochondrial 
dynamics	decline	in	aging	(Seo	et	al.,	2010).	In	skeletal	muscle	of	24‐
month‐old	WT	mice,	we	observed,	along	with	a	severe	reduction	of	
the Pgc‐1α	 transcript	 (Figure	 S1a),	 an	 age‐dependent	 decreased	 ex‐
pression of the fusion genes Mitofusin 1 and 2	(Mfn1 and 2)	and	Optic 
atrophy 1 and 2	(Opa1 and 2;	Figure	1a).	Furthermore,	muscle	OXPHOS	
protein	 content	 was	 diminished	 in	 24‐month‐old	 WT	 mice	 (Figure	
S1b).	 Intriguingly,	 loss	of	PGC‐1α	 in	muscles	of	young	mKO‐PGC‐1α 
animals	decreased	OXPHOS	protein	(Figure	S1b)	and	Mfn1 gene ex‐
pression	 levels	 (Figure	 1a)	 to	 values	 comparable	 to	 those	 obtained	
from	aged	WT	muscles.	Conversely,	PGC‐1α overexpression in young 
mTg‐PGC‐1α muscles strikingly upregulated the levels of Mfn1‐2 and 
Opa1‐2,	 as	well	 as	OXPHOS	proteins,	 and	prevented	 the	age‐linked	
reduction	of	these	genes	and	proteins	(Figure	1a;	Figure	S1b).	In	addi‐
tion,	muscle	PGC‐1α	overexpression	increased	mtDNA	amount	as	well	
as	both	mitochondrial	density	and	size	(Figure	S2a–c),	correlating	with	
elevated	expression	of	the	estrogen‐related	receptor	α	 (Esrra, ERRα)	
and	the	mitochondrial	transcription	factor	A	(Tfam), essential regula‐
tors	of	mitochondrial	biogenesis	and	function	(Figure	S2d).
Besides their role in mitochondrial dynamics, mitofusin proteins, 
in particular Mfn2,	constitute	essential	elements	of	MAMs,	linking	the	
SR and the mitochondrial compartments. In parallel with diminished 
Mfn1 and 2	expression	upon	aging	 in	WT	muscles,	a	significant	 re‐
duction	of	other	essential	mediators	of	the	mitochondria‐SR	commu‐
nication,	such	as	the	glucose‐regulated	protein	75	(GRP75)	and	the	
voltage‐dependent	anion	channel	(VDAC),	was	detected	(Figure1a,b).	
Interestingly,	loss	of	PGC‐1α	in	young	mKO‐PGC‐1α muscles also de‐
creased	VDAC	protein	expression,	while	PGC‐1α overexpression in 
mTg‐PGC‐1α	mice	and	C2C12	cells	resulted	in	higher	levels	of	GRP75	
gene	and	VDAC	protein	expression,	 independent	of	age	of	the	ani‐
mal	(Figure	1a–e).	We	further	demonstrated	that	overexpression	of	
PGC‐1α	 in	C2C12	cells	induces	the	expression	of	Mfn1 and 2, Drp1, 
Fission 1	 (Fis1),	 Opa1‐2, Grp75,	 and	 VDAC	 in	 an	 ERRα‐dependent	
manner	 (Figure	1d,e).	Other	PGC‐1α target genes, for example, the 
BCL2/adenovirus	 E1B	 19‐kDa	 interacting	 protein	 3	 (Bnip3),	 were	
not affected by ERRα	knockdown,	 (Figure	1c).	The	blunting	effects	
of	 PGC‐1α	 overexpression	 on	 age‐induced	 mitochondrial	 changes	
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F I G U R E  1  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	increases	mitochondrial	dynamics	and	sarcoplasmic	
reticulum	(SR)	association	in	an	estrogen‐related	receptor	α	(ERRα)‐dependent	manner	and	improves	muscle	function	during	aging.	(a)	
Relative	muscle	mRNA	levels	of	genes	related	to	mitochondrial	dynamics	and	SR	association	(n	=	6).	(b)	Relative	muscle	voltage‐dependent	
anion	channel	(VDAC)	protein	levels	(n	=	6).	(c	and	d)	Relative	C2C12	cell	mRNA	levels	of	PGC‐1α and ERRα targets and of genes related to 
mitochondrial	dynamics	and	SR	association	(n	=	3	independent	experiments	with	three	technical	replicates).	(e)	Relative	C2C12	cell	VDAC	
protein	levels	(n	=	3	independent	experiments	with	three	technical	replicates).	(f)	Age‐related	reduction	in	spontaneous	locomotor	activity	
measured	by	the	CLAMS	system.	Values	represent	48	hr	of	recording	(n	=	8–9).	(g)	Age‐related	reduction	in	maximal	running	speed	during	
treadmill	exhaustion	test	(n	=	10–12).	Values	are	mean	±	SEM. *p < 0.05; **p < 0.01; ***p < 0.001 indicate statistically significant differences 
between young and old animals of the same genotype or between cells with endogenous and overexpressed ERRα levels, #p < 0.05; 
##p < 0.01; ###p	<	0.001	indicate	statistically	significant	differences	between	genotypes	of	age‐matched	animals	or	between	cells	with	
endogenous	and	overexpressed	PGC‐1α levels
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were	 associated	 with	 a	 mitigation	 of	 the	 age‐related	 reduction	 in	
spontaneous	 locomotion	 and	 endurance	 performance	 (Figure	 1f,g	
and	Figure	S1c,d).	 In	 contrast,	muscle‐specific	PGC‐1α deletion led 
to	a	premature	decrease	 in	running	capacity	 in	12‐month‐old	mKO	
animals	 (Figure	S1c).	These	data	correlate	with	the	balance,	muscle	
strength,	and	fiber	size	changes	upon	PGC‐1α modulation in old ani‐
mals	(Gill,	Santos,	Schnyder,	&	Handschin,	2018).	Together,	these	re‐
sults	clearly	show	that	PGC‐1α is not only an essential regulator of 
mitochondrial function and dynamics in young and old animals, but 
also	prevents	the	age‐associated	decline	of	these	systems.
2.2 | PGC‐1α improves mitochondrial calcium 
handling during aging
A	disrupted	mitochondrial	network,	specifically	the	mitochondria‐SR	
association,	affects	cellular	calcium	homeostasis	(Fernandez‐Sanz	et	
F I G U R E  2  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	ameliorates	mitochondrial	calcium	buffering.	(a)	Relative	
muscle	mRNA	levels	of	mitochondrial	calcium	buffering	genes	(n	=	6).	(b)	Relative	C2C12	myoblasts	mRNA	levels	of	mitochondrial	calcium	
buffering	genes	(n	=	3	independent	experiments	with	three	technical	replicates).	(c)	Relative	mitochondrial	calcium	uptake	(left	panel)	and	
removal	(right	panel)	in	FDB	fibers	of	28‐month‐old	animals.	(d	and	e)	Representative	extra‐mitochondrial	calcium	traces	upon	calcium	
injection	and	quantification	of	relative	extra‐mitochondrial	calcium	levels	after	a	total	addition	of	150	μm of calcium. Squares indicate the 
baseline	and	assay	values	used	for	quantifications	shown	in	(e)	(n = 4; two independent experiments with two muscles of each genotype 
used	in	each	experiment).	(f)	Representative	pictures	of	mitochondrial	pellets	after	mitochondria	isolation	from	hindlimb	muscles	and	
measure	of	isolated	mitochondrial	quantity.	(g)	Total	mitochondrial	calcium	buffering	capacity	calculated	by	multiplying	total	mitochondrial	
quantity	by	the	percentage	of	calcium	imported	in	the	mitochondria.	Values	are	mean	±	SEM. *p < 0.05; **p < 0.01; ***p < 0.001 indicate 
statistically significant differences between young and old animals of the same genotype or between cells with endogenous and 
overexpressed	estrogen‐related	receptor	α	(ERRα)	levels,	#p < 0.05; ##p < 0.01; ###p < 0.001 indicate statistically significant differences 
between	genotypes	of	age‐matched	animals	or	between	cells	with	endogenous	and	overexpressed	PGC‐1α levels
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al.,	2014;	Pietrangelo	et	al.,	2015).	Our	group	has	previously	dem‐
onstrated	 that	 PGC‐1α	 modulates	 SR‐controlled	 calcium	 levels	 in	
skeletal	muscle	 (Summermatter	 et	 al.,	 2012),	 but	 the	 involvement	
of	PGC‐1α in regulating mitochondrial calcium uptake capacity and 
the	 exchange	 between	mitochondria	 and	 the	 SR	 is	 unknown.	We	
observed that aging significantly reduced the expression of genes 
involved in mitochondrial calcium uptake and transfer from the SR, 
including	the	leucine	zipper	and	EF‐hand	containing	transmembrane	
protein	 1	 (Letm1)	 and	 the	 inositol	 1,4,5‐trisphosphate	 (IP3)	 recep‐
tor	 type	1	 (Itpr1)	 in	WT	muscles	 (Figure	2a).	 Interestingly,	PGC‐1α 
upregulation prevented the age decline of Iptr1 and Letm1 and sig‐
nificantly upregulated genes related to mitochondrial calcium buff‐
ering in the muscle of old mice, including the mitochondrial calcium 
uniporter	(Mcu)	gene	(Figure	2a).	The	effect	of	PGC‐1α on Mcu and 
Letm1	 was	 recapitulated	 in	 cultured	 myotubes	 (Figure	 2b).	 The	
PGC‐1α‐mediated	 induction	of	 the	expression	of	 these	 two	genes	
was furthermore dependent on ERRα	 (Figure	2b).	 Intriguingly,	 the	
genes encoding proteins related to calcium exchange that form an 
organelle‐spanning	complex	to	control	mitochondria‐SR	interactions	
at	MAMs	were	 all	 downregulated	 in	old	WT	mice,	 and	 rescued	 in	
old	mTg‐PGC‐1α animals, including Itpr1 on the SR side, Grp75 pro‐
viding a link between SR and mitochondria, and Vdac on the mito‐
chondrial	 side.	The	 tethering	of	 this	complex	 to	both	organelles	 is	
supported by the additional link provided by the mitofusins, which 
exhibit	a	similar	regulation.	Of	note,	 this	age‐related	dysregulation	
was	 at	 least	 in	 part	 exacerbated	 by	 knockout	 of	 PGC‐1α.	 To	 test	
whether these changes affect calcium handling, mitochondrial cal‐
cium	uptake	in	flexor	digitorum	brevis	(FDB)	muscle	fibers	isolated	
from	old	mTg‐PGC‐1α	and	WT	mice	was	assessed.	In	line	with	the	in‐
creased	expression	of	MAM	calcium	exchange	genes,	mitochondria	
in FDB fibers of old muscle buffered more calcium when comparing 
mTG‐PGC‐1α	to	WT	mice	(Figure	2c).	Calcium	removal	kinetics	were	
however	not	different	between	the	genotypes	(Figure	2c).	Next,	the	
autonomous calcium buffering capacity of isolated mitochondria 
was	 investigated.	We	 found	 that	 after	 the	 addition	 of	 150	µM	of	
calcium,	calcium	uptake	was	higher	in	mTg‐PGC‐1α	compared	to	WT	
mitochondria	(Figure	2d,e	and	Figure	S2e).	Since	equal	amounts	of	
isolated	mitochondria	(275	µg)	were	used	for	these	measurements,	
the results indicate that when normalized to mitochondrial amount, 
mitochondria	 from	mTg‐PGC‐1α animals have an improved intrin‐
sic	calcium	buffering	capacity	compared	to	mitochondria	from	WT	
mice.	Thus,	when	considering	the	higher	total	mitochondrial	mass	in	
the	gain‐of‐function	model	 (Figure	2f),	 the	total	mitochondrial	cal‐
cium	buffering	capacity	of	skeletal	muscle	in	mTg‐PGC‐1α animals is 
even	further	amplified	(Figure	2g).
2.3 | PGC‐1α prevents ER stress and tubular 
aggregate formation in the aging muscle
Dysregulated calcium exchange between the ER and mitochondria 
is	linked	to	ER	stress	(Malhotra	&	Kaufman,	2011).	To	test	whether	
the	 modulation	 in	 mitochondria‐SR	 interaction	 and	 mitochon‐
drial calcium buffering affects the SR, the extent of ER stress was 
investigated	in	the	muscles	of	our	mouse	cohorts.	We	observed	that	
ER stress increases with age as demonstrated by elevated expres‐
sion	of	the	X‐box	binding	protein	1	(Xbp1)	and	the	chaperone	protein	
BIP	in	WT	and	mKO‐PGC‐1α muscles, but not to the same extent in 
mTg‐PGC‐1α	animals	(Figure	3a,b).	Furthermore,	PGC‐1α muscle de‐
letion led to an increased activation of the calcium stress marker cas‐
pase	12,	which	was	exacerbated	with	age	(Figure	3b).	Consistently,	
poly‐ubiquitination	of	proteins,	 indicative	of	proteasomal	degrada‐
tion of potentially misfolded proteins, was dramatically increased in 
mKO‐PGC‐1α muscles with age and reduced in both young and old 
muscles	of	mTg‐PGC‐1α	mice	(Figure	S3a).	Of	note,	the	in	vivo	reduc‐
tion of Xbp1	mRNA	levels	and	protein	poly‐ubiquitination	by	PGC‐1α 
were	recapitulated	in	differentiated	C2C12	cells	(Figure	S3b,c).
Overload of SR function results in a compensatory increase in SR 
membranes and ultimately the development of tubular aggregates, for 
example,	as	reported	in	muscle	fibers	of	old	mice	(Agbulut,	Destombes,	
Thiesson,	 &	 Butler‐Browne,	 2000).	On	 histological	 sections,	we	 no‐
ticed	the	presence	of	abnormal	eosin‐labeled	structures	in	tibialis	an‐
terior	 (TA)	muscles	of	old	WT	and	mKO‐PGC‐1α	animals	 (Figure	3c),	
confirmed as tubular aggregates by positive staining for the SR marker 
calsequestrin	 1	 (CSQ1)	 in	 TA	 (Figure	 3d),	 and	 electron	 microscopy‐
based	 analysis	 of	 old	WT	 and	mKO‐PGC‐1α gastrocnemius muscles 
(Figure	 S4a).	 Interestingly,	 the	 age‐dependent	 occurrence	 of	 tubular	
aggregates	doubled	in	TA	muscles	of	old	mKO‐PGC‐1α	compared	age‐
matched	WT	animals	 (Figure	3e).	Remarkably,	no	 tubular	aggregates	
were	detected	 in	 fast	and	mixed	muscles	of	aged	mTg‐PGC‐1α mice 
(Figure	3c,e	and	Figure	S4a).	Tubular	aggregates	were	likewise	absent	
in	the	old	oxidative	soleus	muscle	(Figure	S4b)	and	reduced	succinate	
dehydrogenase	(SDH)‐positive	fibers	of	other	muscle	beds	in	old	WT	
and	mKO‐PGC‐1α	mice	(Figure	S4c),	suggesting	a	link	to	the	respec‐
tive	metabolic	fiber	type.	The	formation	of	tubular	aggregates	is	closely	
associated	 with	 the	 accumulation	 of	 CSQ1	 and	 other	 SR	 proteins,	
which might subsequently overwhelm the unfolded protein response 
(Chevessier	et	al.,	2005).	Thus,	along	with	the	absence	of	tubular	aggre‐
gate	formation	in	muscle	of	old	mTg‐PGC‐1α mice, elevation of muscle 
PGC‐1α	 levels	 prevented	 the	 age‐related	 increase	 of	 CSQ1	 protein	
levels	that	is	observed	in	WT	and	mKO‐PGC‐1α	mice	(Figure	3f).	The	
acute	reduction	of	CSQ1	protein	and	transcript	levels	in	cultured	myo‐
tubes	overexpressing	PGC‐1α implies that this effect is at least in part 
directly	linked	to	PGC‐1α, and not only relies on indirect, secondary ef‐
fects	of	a	fiber‐type	shift	(Figure	3g).	Of	note,	in	addition	to	the	tubular	
aggregates,	electron	microscopy	also	revealed	other	age‐linked,	abnor‐
mal structures of unknown origin and function in muscles fibers of old 
mKO‐PGC‐1α	and	WT	mice	that	were	absent	from	the	young	animals	
of	 all	 three	 genotypes	 and	 from	old	mTg‐PGC‐1α	mice	 (Figure	 S4d),	
indicating	further	age‐associated	abnormalities	and	damage	in	skeletal	
muscle	that	can	be	prevented	by	high	levels	of	PGC‐1α.
2.4 | PGC‐1α reduces the activation of cell death 
pathways in muscle of old animals
Abnormal	mitochondrial	function,	ER	stress	response,	mitochondria‐
SR interaction, and calcium homeostasis have all been described in the 
6 of 13  |     GILL et aL.
context	of	the	initiation	of	cell	death	(Danese	et	al.,	2017).	We	there‐
fore	 assessed	 whether	 age‐associated	 apoptosis	 in	 skeletal	 muscle	
was	affected	by	modulation	of	PGC‐1α. P53, a major regulator of cell 
death	induction	upon	DNA	damage	and	other	stress	conditions,	was	
upregulated	during	aging	of	WT	and	mKO‐PGC‐1α muscles, but not in 
mTg‐PGC‐1α	muscle	overexpressing	PGC‐1α	(Figure	4a).	Compared	to	
aged	WT	animals,	muscles	of	old	mKO‐PGC‐1α	and	mTg‐PGC‐1α mice 
exhibited,	respectively,	trends	toward	a	twofold	increase	(p	=	0.06)	and	
a	twofold	decrease	(p	=	0.05)	in	P53	protein	levels.	Interestingly,	mRNA	
levels	of	the	pro‐apoptotic	insulin‐like	growth	factor	binding	protein	
5	 (Igfbp5)	and	of	 the	p53	targets	p21	and	BCL2‐binding	component	
3	(Puma) followed a similar pattern of expression, implying increased 
activity	 of	 P53	 in	 old	WT	 and	mKO‐PGC‐1α,	 but	 not	 mTg‐PGC‐1α 
mice	(Figure	4b).	The	transcript	levels	of	the	cell	survival‐related	gene	
F I G U R E  3  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	reduces	endoplasmic	reticulum	(ER)	stress	during	
aging	and	prevents	age‐related	tubular	aggregate	formation.	(a	and	b)	Relative	muscle	mRNA	and	protein	levels	of	ER	stress‐related	
genes	(n	=	5–6).	(c)	Representative	pictures	of	H&E‐stained	tibialis	anterior	cryosection,	scale	bars	represent	50	µm.	(d)	Colocalization	
of	H&E	labeled	aggregates	(left	picture)	with	calsequestrin	1	staining	(right	picture)	indicated	by	arrows,	scale	bars	represent	100	µm.	
(e)	Representative	pictures	of	tubular	aggregates	stained	with	calsequestrin	1	antibody	and	quantification	of	the	percentage	of	fibers	
containing	tubular	aggregates,	scale	bars	represent	50	µm	(n	=	6).	(f	and	g)	Calsequestrin	1	protein	levels	in	muscles	of	young	and	old	animals	
and	in	C2C12	myotubes	(n	=	3	independent	experiments	with	three	technical	replicates).	Values	are	mean	±	SEM. *p < 0.05; **p < 0.01; 
***p < 0.001 indicate statistically significant differences between young and old animals of the same genotype, #p < 0.05; ##p < 0.01; 
###p	<	0.001	indicate	statistically	significant	differences	between	genotypes	of	age‐matched	animals	or	between	cells	with	endogenous	and	
overexpressed	PGC‐1α levels
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X‐linked	inhibitor	of	apoptosis	protein	(Xiap)	were	downregulated	with	
age	in	WT	and	mKO‐PGC‐1α	muscles	and	cyclin	D	transcript	(Ccnd1)	
expression	was	 lower	 in	 old	mKO‐PGC‐1α	 muscles	 relative	 to	 age‐
matched	WT	muscles.	PGC‐1α significantly elevated the expression of 
all	pro‐survival	genes	in	young,	and	Xiap	mRNA	levels	in	old,	muscles	
of	mTg‐PGC‐1α	mice	(Figure	4b).	Caspase	3	cleavage,	a	marker	of	cell	
death,	was	increased	with	age	in	mKO‐PGC‐1α mice and significantly 
higher	in	muscles	of	old	mKO‐PGC‐1α	mice	relative	to	muscles	of	age‐
matched	WT	animals	 (Figure	4c).	Additionally,	 in	old	muscle	tissues,	
the	smallest	cleavage	product	of	caspase	3	was	reduced	by	PGC‐1α 
overexpression.	 Taken	 together,	 our	 findings	 suggest	 a	 protective	
function	of	muscle	PGC‐1α	against	age‐induced	muscle	cell	death.
2.5 | PGC‐1α protects against ceramide‐ and 
thapsigargin‐induced cell death
To	 evaluate	 the	 direct	 influence	 of	 PGC‐1α on cell death, we used 
ceramide, which acts as a second messenger for apoptosis linked to 
ER stress, mitochondrial impairment, and dysregulation of calcium 
homeostasis	 (Jarvis,	 Grant,	 &	 Kolesnick,	 1996),	 hence	 a	 number	 of	
events	that	we	also	observed	in	muscle	aging	in	vivo.	We	observed	
that	 PGC‐1α	 overexpression	 protected	C2C12	 cells	 following	 cera‐
mide exposure as evaluated by microscopy and by a propidium io‐
dide‐based	 cell	 death	 assay	 (Figure	 5a,b).	 Of	 note,	 similar	 findings	
have	been	reported	in	HeLa	cells	(Bianchi	et	al.,	2006).	Furthermore,	
PGC‐1α overexpression in muscle cells abolished the induction of 
p53, reduced the cleavage of caspase 3 proteins, and alleviated the 
increase	 in	 expression	 of	 the	 DNA	 damage	 marker	 phospho‐H2A	
histone	 family	 member	 X	 (pH2AX)	 in	 response	 to	 ceramide	 treat‐
ment	(Figure	5c).	Inversely,	protein	levels	of	the	phosphorylated	form	
of	 the	 phospho‐prepro‐retinoblastoma‐associated	 protein	 (ppRb),	
which represents an inactive state of this protein involved in trigger‐
ing	apoptosis	upon	DNA	damage	(Ianari	et	al.,	2009),	were	increased	
by	 PGC‐1α	 (Figure	 5c).	 Moreover,	 PGC‐1α upregulation abrogated 
ceramide‐dependent	 changes	 of	 gene	 expression	 related	 to	 cell	
death	and	 survival	 (Figure	5d).	Next,	we	assessed	whether	PGC‐1α 
F I G U R E  4  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	inhibits	age‐related	muscle	cell	death.	(a–c)	Relative	
muscle	mRNA	and	protein	levels	of	cell	death	and	cell	survival‐related	genes	(n	=	5–6).	Values	are	mean	±	SEM. *p < 0.05; **p < 0.01; 
***p < 0.001 indicate statistically significant differences between young and old animals of the same genotype, #p < 0.05; ##p < 0.01; 
###p	<	0.001	indicate	statistically	significant	differences	between	genotypes	of	age‐matched	animals
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F I G U R E  5  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	protects	from	ceramide‐induced	cell	death.	(a	and	b)	
Representative	pictures	of	myotubes	and	propidium	iodide	incorporation	in	myoblasts	with	endogenous	or	increased	PGC‐1α levels after 
ceramide	or	DMSO	treatment.	(c)	Relative	protein	levels	of	P53	and	ppRB	in	myotubes	and	caspase	3	and	pH2AX	in	myoblasts.	(d)	Relative	
myotube	mRNA	levels	of	cell	death	and	cell	survival	markers	(n	=	3	independent	experiments	with	three	technical	replicates).	Values	are	
mean	±	SEM. *p < 0.05; **p < 0.01; ***p	<	0.001	indicate	statistically	significant	differences	between	cells	treated	with	DMSO	and	ceramide,	
#p < 0.05; ##p < 0.01; ###p	<	0.001	indicate	statistically	significant	differences	between	cells	with	endogenous	and	overexpressed	PGC‐1α 
levels
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protects myocytes from cell death specifically induced by cytosolic 
calcium	dysregulation.	Therefore,	we	treated	myocytes	with	thapsi‐
gargin	(TPG),	a	noncompetitive	inhibitor	of	the	ATPase	sarcoplasmic/
endoplasmic	reticulum	Ca2+	transporting	(SERCA),	which	blocks	SR	
calcium uptake and promotes apoptosis through a dramatic increase 
in	cytosolic	calcium	and	ER	stress	(Chen,	Chiang,	Hung,	Hung,	&	Lai,	
2000).	Similar	to	its	protective	role	after	ceramide	treatment,	PGC‐1α 
protected	muscle	 cells	 from	 TPG‐induced	 apoptosis	 (Figure	 S5a,b).	
This	protective	effect	was	accompanied	by	a	reduction	of	TPG‐medi‐
ated	caspase	3	activation	and	pH2AX	protein	elevation	(Figure	S5c).	
At	the	same	time,	the	downregulation	of	ppRB	protein	levels	by	TPG	
was	prevented	by	PGC‐1α	overexpression	(Figure	S5c).	Notably,	un‐
like	ceramide,	TPG	did	not	affect	p53	protein	 levels,	 indicating	that	
ceramide	and	TPG	induce	apoptosis	through	at	least	in	part	different	
pathways,	both	of	which	are	affected	by	PGC‐1α.	Together,	these	data	
suggest	an	essential	role	for	PGC‐1α in the prevention of cell death.
3  | DISCUSSION
Peroxisome	proliferator‐activated	receptor	γ coactivator 1α is a key 
regulator of mitochondrial biogenesis, dynamics, and function in 
young	 animals.	Moreover,	 the	 effects	 of	 this	 transcriptional	 coac‐
tivator extend to other organelles and cell compartments, such as 
the	unfolded	protein	response	after	exercise	 (Wu	et	al.,	2011)	and	
SR‐controlled	 calcium	 homeostasis	 (Summermatter	 et	 al.,	 2012).	
We	describe	here	a	novel	PGC‐1α‐regulated	pathway	involving	the	
collective control of the function and interaction between mito‐
chondria and the SR centered on calcium homeostasis. Our findings 
accordingly provide a mechanistic and functional link between the 
observed	decline	in	PGC‐1α expression and the ensuing reduction in 
mitochondrial dynamics and activity in muscle at old age that have 
been reported previously.
Mitochondrial	 calcium	 uptake	 is	 important	 for	 electron	 trans‐
port	chain	function	and	hence	ATP	production,	but	also	significantly	
contributes to the modulation of intramyocellular resting calcium 
levels	 (Rizzuto	 et	 al.,	 2012).	 For	 example,	 the	 age‐related	 decline	
in mitochondrial calcium buffering capacity leads to a rise in intra‐
cellular	 calcium	 levels	 in	 old	muscle	 (Fernandez‐Sanz	 et	 al.,	 2014;	
Pietrangelo	et	al.,	2015).	The	 improved	calcium	buffering	capacity	
of	mitochondria	from	muscles	overexpressing	PGC‐1α can therefore 
blunt much of the stress exerted by increased intracellular calcium in 
this context. Besides direct mitochondrial calcium uptake, improved 
mitochondrial	function	and	ATP	production	help	to	maintain	calcium	
reuptake	into	the	SR	via	the	ATP‐dependent	calcium	pumps	(Allen,	
Lamb,	 &	Westerblad,	 2008).	 Concurrently,	 the	 reduction	 in	 poly‐
ubiquitinated proteins and the expression of Xbp1 and BIP indicate 
a	PGC‐1α‐dependent	alleviation	of	the	SR	burden.	Complete	abro‐
gation	of	tubular	aggregates	formation	by	PGC‐1α further illustrates 
the muscle protection from ER stress development and escalation to 
tubular aggregates during aging.
Tubular	aggregates	are	predominantly	composed	of	small,	densely	
packed	tubules	arising	from	SR	(Chevessier,	Marty,	Paturneau‐Jouas,	
Hantai,	 &	 Verdiere‐Sahuque,	 2004)	 and	 are	 associated	 with	 both	
natural	 and	premature	 aging	 in	mice	 (Agbulut	 et	 al.,	 2000).	 In	hu‐
mans, tubular aggregates have likewise been reported in old mus‐
cle	(Tomonaga,	1977),	but	are	also	prominently	observed	in	several	
other pathological conditions, including peripheral neuropathies, 
amyotrophic	 lateral	 sclerosis	 and	myotonic	 dystrophy	 (Chevessier	
et	al.,	2005;	Schiaffino,	2012).	Moreover,	these	abnormal	structures	
represent the predominant symptom in tubular aggregate myopathy 
(Schiaffino,	2012).	Due	to	their	calcium	loading	capacity,	tubular	ag‐
gregates are alternatively thought to be a compensatory mechanism 
to	counteract	age‐associated	cellular	calcium	increase,	rather	than	a	
consequence of dysregulated calcium metabolism. Here, we report 
that	PGC‐1α overexpression fully protects muscle from tubular ag‐
gregate	formation	in	old	mice,	while	muscle	ablation	of	the	PGC‐1α 
gene markedly exacerbates tubular aggregate occurrence during 
aging	(Figure	3	and	Figure	S4)	or,	as	previously	reported,	upon	de‐
nervation	 (Vainshtein,	 Desjardins,	 Armani,	 Sandri,	 &	Hood,	 2015).	
Moreover,	a	 link	between	impaired	mitochondrial	calcium	handling	
and tubular aggregate formation was reported in young mitochon‐
drial	 calcium	uptake	1	 (MICU1)	 knockout	mice,	which	 recapitulate	
some	of	the	phenotype	of	old	WT	and	young	and	old	PGC‐1α knock‐
out muscle, including mitochondrial dysfunction, impaired muscle 
function	and	the	formation	of	tubular	aggregates	(Liu	et	al.,	2016).	
In parallel to improving calcium homeostasis and downregulation of 
proteins	that	accumulate	in	tubular	aggregates	such	as	CSQ1,	a	cen‐
tral	 role	for	PGC‐1α in this context is further substantiated by our 
SDH staining and electron microscopy data as well as other studies 
that revealed a strong preference for tubular aggregate formation in 
glycolytic	fibers	(Funk	et	al.,	2013).	The	potent	effect	of	PGC‐1α in 
driving	an	oxidative	muscle	fiber	shift	(Gill	et	al.,	2018;	Handschin,	
Chin,	et	al.,	2007;	Lin	et	al.,	2002)	thus	likely	further	contributes	to	
the inhibition of tubular aggregate formation. In light of our data, 
it	would	be	interesting	to	study	whether	increased	muscle	PGC‐1α 
levels prevent tubular aggregate formation in mice with tubular ag‐
gregate‐associated	myopathies.
Mitochondrial	 dysfunction,	 ATP	 depletion,	 calcium	 dysregula‐
tion,	and	ER	stress,	as	observed	in	old	WT	and	mKO‐PGC‐1α mice, 
are	strong	promoters	of	cell	death	(Danial	&	Korsmeyer,	2004).	The	
protective	effect	of	muscle	PGC‐1α on mitochondrial and SR func‐
tion could thus directly or indirectly result in the observed reduc‐
tion of cell death initiation. Similar to our in vivo observations, the 
induction	of	 cell	 death	 in	C2C12	 cells	 upon	ER	 and	mitochondrial	
stressors	(e.g.,	as	evoked	by	ceramide)	or	abnormal	cellular	calcium	
elevation	 (e.g.,	 as	 triggered	 by	 TPG)	 is	 inhibited	 when	 PGC‐1α is 
overexpressed.	Interestingly,	the	anti‐apoptotic	function	of	PGC‐1α 
has previously been suggested in a number of tissues, including the 
retina	(Egger	et	al.,	2012),	vascular	endothelial	cells	(Valle,	Alvarez‐
Barrientos,	Arza,	Lamas,	&	Monsalve,	2005),	neurons	(Luo,	Zhu,	Jia,	
Zhang,	 &	 Xu,	 2009),	 and	 skeletal	 muscle	 (Adhihetty	 et	 al.,	 2009).	
Our	findings	now	provide	direct	evidence	of	a	broader	PGC‐1α‐con‐
trolled program that links functional mitochondria, SR, and calcium 
handling to cell death regulation in muscle, which becomes compro‐
mised	with	 decreased	 PGC‐1α expression during aging, and likely 
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leads to higher rates of myofiber apoptosis. Indeed, decreased levels 
of	various	indicators	in	old	PGC‐1α overexpressing animals strongly 
suggest	that	PGC‐1α	protects	muscle	against	age‐related	cell	death.	
The	effect	of	PGC‐1α	on	P53,	pH2AX,	and	ppRb	expression	that	we	
described are reminiscent of findings in vascular endothelial cells, 
in	which	a	telomere‐P53‐PGC‐1α axis has been postulated to be in‐
volved	 in	 regulating	 apoptosis	 and	 senescence	 (Sahin	 et	 al.,	 2011;	
Xiong,	Patrushev,	Forouzandeh,	Hilenski,	&	Alexander,	2015).	A	sim‐
ilar signaling cascade could accordingly be involved in modulating 
DNA	damage	and	cellular	senescence	in	old	skeletal	muscle.
In	summary,	our	results	demonstrate	that	PGC‐1α, in close rela‐
tion with ERRα, is central in the coordinated control of SR and mi‐
tochondrial calcium homeostasis, thereby preventing SR stress and 
activation	of	cell	death	pathways	(Figure	6).	Intriguingly,	this	control	
is	exerted	in	a	context‐specific	manner:	For	example,	while	PGC‐1α 
upregulates the unfolded protein response to cope with the acute 
consequences	of	exercise	(Wu	et	al.,	2011),	increased	muscle	PGC‐1α 
in	old	muscle	alleviates	the	aging‐related	burden	on	the	SR	by	lower‐
ing	the	ER	stress	response.	Accordingly,	mKO‐PGC‐1α mice in many 
regards	 exhibit	 a	 premature	 aging	 phenotype	 (present	 results	 and	
ref.	Gill	et	al.,	2018).	Along	the	same	line,	these	animals	have	previ‐
ously	been	reported	to	suffer	from	exacerbated	age‐related	glucose	
intolerance	and	systemic	inflammation	(Sczelecki	et	al.,	2014).	This	is	
different	from	cardiac	tissue,	where	a	reduction	in	PGC‐1α gene ex‐
pression has a limited effect on aging, mainly affecting mitochondrial 
gene	 expression	 (Whitehead,	 Gill,	 Brink,	 &	 Handschin,	 2018).	
Inversely,	PGC‐1α	elevation	improved	both	cardiac	(Whitehead	et	al.,	
2018)	 and	 skeletal	muscle	 function	 in	 old	mTg‐PGC‐1α mice, over‐
all	positively	affecting	health‐adjusted	life	expectancy	(health	span),	
thus the length of time of life in a healthy state, as evidenced by 
preserved	locomotion	and	exercise	capacity	(Figure	1f,g),	as	well	as	
balance	and	motor	coordination	 (Gill	 et	al.,	2018).	Our	 findings	are	
furthermore corroborated by a recent publication reporting a de‐
layed	aging	process	of	mTg‐PGC‐1α animals in terms of global gene 
expression patterns, markers for mitochondrial function and muscle 
wasting,	 and	morphology	of	 the	neuromuscular	 junction	 (Garcia	et	
al.,	2018).	Interestingly,	while	mTg‐PGC‐1α exhibit such an extension 
in	health	span,	alteration	of	muscle	PGC‐1α expression did not affect 
overall	lifespan	in	our	study	(Figure	S6).	A	modest	increase	(~5%)	in	
median	 lifespan	has	however	recently	been	reported	 in	those	mTg‐
PGC‐1α mice that reached a minimal age of 800 days, but not when 
all	animals	were	analyzed	(Garcia	et	al.,	2018),	indicating	a	subtle	ben‐
eficial	effect	of	muscle	PGC‐1α	on	survival	in	old	mice.	Collectively,	
our present findings reveal a novel cascade of cellular processes 
explaining	how	PGC‐1α	affects	muscle	health	in	aging,	involving	SR‐
mitochondrial interaction linked to calcium handling, SR stress, and 
cell	death	pathway	activation	(Figure	6).	 In	 light	of	our	present	and	
other	recent	findings	(Garcia	et	al.,	2018;	Gill	et	al.,	2018;	Sczelecki	
et	al.,	2014),	PGC‐1α modulation, for example, by exercise or pharma‐
cological interventions, represents an attractive approach to reduce 
F I G U R E  6  Peroxisome	proliferator‐activated	receptor	γ coactivator 1α	(PGC‐1α)	regulation	of	calcium	and	cell	death	during	skeletal	
muscle	aging.	Aging	and	PGC‐1α	downregulation	impair	mitochondrial	respiration,	calcium	import,	and	sarcoplasmic	reticulum	(SR)‐
association	leading	to	exacerbated	cytosolic	calcium	increase	and	SR	stress,	which	ultimately	results	in	tubular	aggregate	formation.	Those	
cellular	dysregulations	all	contribute	to	promote	muscle	apoptosis.	PGC‐1α elevation improves mitochondrial function and calcium buffering, 
preserving	calcium	homeostasis	and	preventing	tubular	aggregate	development	during	aging.	Together	with	the	reduction	of	those	cellular	
insults,	PGC‐1α inhibits apoptosis initiation, thereby further protecting muscle from cell death
Skeletal muscleAging Aging + PGC-1α
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MCU
ATP
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α 
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weakness, frailty, and other pathological alterations associated with 
skeletal muscle aging, along with additional potential benefits on the 
heart	(Whitehead	et	al.,	2018).
4  | E XPERIMENTAL PROCEDURES
4.1 | Animals and reagents
Mice	with	muscle‐specific	PGC‐1α	deletion	(mKO‐PGC‐1α)	or	over‐
expression	 (mTg‐PGC‐1α)	 were	 previously	 described	 (Handschin,	
Chin,	 et	 al.,	 2007;	Handschin,	 Choi,	 et	 al.,	 2007;	 Lin	 et	 al.,	 2002).	
C57/Bl6	wild‐type	(WT)	mice	were	obtained	from	Janvier.	Male	mice	
were studied at 3 and 24 months of age unless otherwise stated. 
All	 experiments	 were	 performed	 in	 accordance	 with	 the	 federal	
guidelines for animal experimentation and were approved by the 
Kantonales	Veterinäramt	of	the	Kanton	Basel‐Stadt.
Primary	 antibodies	 were	 obtained	 from	 Cell	 Signaling,	 Thermo	
Scientific,	Abcam,	Sigma,	or	Enzo,	and	secondary	antibodies	from	Dako,	
Jackson	Immunoresearch,	or	Life	Technologies.	General	reagents	were	
purchased	 from	Sigma‐Aldrich.	Detailed	methodological	 information	
about	muscle	preparation,	physical	activity,	histology,	DNA/RNA	ex‐
traction	and	qPCR,	protein	extraction	and	Western	blots,	cell	culture	
experiments, mitochondrial respiration and calcium handling, and sta‐
tistical	analysis	can	be	found	in	the	Supplementary	Material.
4.2 | Transmission electron microscopy
Sample preparation and mitochondrial volume density calculations 
were	performed	as	previously	described	(Arnold	et	al.,	2014).	Briefly,	
volume density is defined as the ratio of test points residing within 
mitochondria and the total amount of test points within the field 
of view; using the measurement tool in Photoshop, the number of 
pixels contained within mitochondria was compared to the total 
number	of	pixels	 in	each	 image.	Mitochondria	were	 identified	and	
outlined	manually.	Mitochondrial	size	was	measured	as	the	pixel	area	
contained	in	each	mitochondrion,	adjusted	to	µm2 scale correspond‐
ing to image magnification. Five images were quantified per block of 
stained	muscle	tissue,	for	a	total	of	five	blocks	per	mouse.	Averages	
of mitochondrial size were taken across all mitochondria measured 
per mouse.
Further descriptions of methods are included in the 
Supplementary	Material.
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